Bladder sarcoidosis presenting with clot-forming gross hematuria: a case report

Abstract Brief introduction Direct bladder involvement by sarcoidosis is exceptionally rare and may mimic urothelial malignancy or infectious granulomatous cystitis. We report a case presenting with clot-forming gross hematuria in which the integrated clinical and pathological findings favored bladder sarcoidosis and the cystoscopic response to systemic glucocorticoids was objectively documented. Case summary A 60-year-old African American man with biopsy-proven pulmonary sarcoidosis, off sarcoidosis-directed therapy since 2016, presented in February 2018 with two weeks of painless gross hematuria progressing to clot passage. Cystoscopy showed multifocal smooth, broad-based, sessile, nonpapillary bladder lesions. The contemporaneous bladder-biopsy pathology report documented well-formed non-necrotizing epithelioid granulomas without urothelial atypia or malignancy in the sampled tissue; Ziehl-Neelsen and Grocott-Gomori methenamine silver stains were negative. CT urography, urine cytology, mycobacterial or fungal tissue cultures, and molecular testing were not performed, limiting definitive exclusion of synchronous upper-tract malignancy and infection. Prednisone 20 mg/day was restarted and tapered over approximately six months. Gross hematuria ceased by day 12, urinalysis showed no hematuria at three weeks, and cystoscopy at four months demonstrated complete lesion resolution. No recurrent gross hematuria or clot passage was documented during 12 months of clinical follow-up. Conclusion Bladder sarcoidosis should be considered in patients with established sarcoidosis and granulomatous bladder lesions, but diagnosis requires clinicopathological correlation and careful exclusion of competing causes. Clinical and cystoscopic response to glucocorticoids is supportive rather than diagnostic and does not replace complete hematuria evaluation or appropriate microbiological assessment.

Authors

Institutions

Publication Details

Journal
Journal of Rare Diseases
Published
2026-09-29
DOI
https://doi.org/10.1007/s44162-026-00239-6
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Bladder sarcoidosis presenting with clot-forming gross hematuria: a case report

Abel Antonio Ricardez Espinosa, Alfredo Augusto Moya Márquez, Eunice Vite Martínez, Guillermo Giovanni Jiménez Cervantes
Journal of Rare Diseases
Sarcoidosis and Beryllium Toxicity Research
article

Bladder sarcoidosis presenting with clot-forming gross hematuria: a case report

Abel Antonio Ricardez Espinosa, Alfredo Augusto Moya Márquez, Eunice Vite Martínez, Guillermo Giovanni Jiménez Cervantes
article en

Abstract

Abstract Brief introduction Direct bladder involvement by sarcoidosis is exceptionally rare and may mimic urothelial malignancy or infectious granulomatous cystitis. We report a case presenting with clot-forming gross hematuria in which the integrated clinical and pathological findings favored bladder sarcoidosis and the cystoscopic response to systemic glucocorticoids was objectively documented. Case summary A 60-year-old African American man with biopsy-proven pulmonary sarcoidosis, off sarcoidosis-directed therapy since 2016, presented in February 2018 with two weeks of painless gross hematuria progressing to clot passage. Cystoscopy showed multifocal smooth, broad-based, sessile, nonpapillary bladder lesions. The contemporaneous bladder-biopsy pathology report documented well-formed non-necrotizing epithelioid granulomas without urothelial atypia or malignancy in the sampled tissue; Ziehl-Neelsen and Grocott-Gomori methenamine silver stains were negative. CT urography, urine cytology, mycobacterial or fungal tissue cultures, and molecular testing were not performed, limiting definitive exclusion of synchronous upper-tract malignancy and infection. Prednisone 20 mg/day was restarted and tapered over approximately six months. Gross hematuria ceased by day 12, urinalysis showed no hematuria at three weeks, and cystoscopy at four months demonstrated complete lesion resolution. No recurrent gross hematuria or clot passage was documented during 12 months of clinical follow-up. Conclusion Bladder sarcoidosis should be considered in patients with established sarcoidosis and granulomatous bladder lesions, but diagnosis requires clinicopathological correlation and careful exclusion of competing causes. Clinical and cystoscopic response to glucocorticoids is supportive rather than diagnostic and does not replace complete hematuria evaluation or appropriate microbiological assessment.

Journal of Rare DiseasesVol. 5(1)
Mexican Social Security Institute (MX), Hospital de Especialidades (MX)
Reduced inequalities
Openalex Percentile: Top 12%
Sarcoidosis and Beryllium Toxicity Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.